NCT06796309

Brief Summary

This clinical trial aims to analyze the usability and degree of satisfaction of two populations, healthcare personnel (Population 1) in rural areas and their patients (Population 2), with the TRAK tele-rehabilitation tool. Participants will undergo telerehabilitation treatment through the TRAK platform for eight weeks (treatment group) or follow an at home exercise protocol (control group).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
95

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 7, 2024

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

January 7, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 28, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

April 8, 2025

Status Verified

April 1, 2025

Enrollment Period

1.2 years

First QC Date

January 7, 2025

Last Update Submit

April 7, 2025

Conditions

Keywords

shoulder paintelerehabilitationtelemedicineexercise programphysiotherapyhealthcare personnel

Outcome Measures

Primary Outcomes (2)

  • Telemedicine Usability Questionnaire (TUQ).

    The TUQ is a questionnaire specifically designed to measure (from 17 to 109 points) the usability of telemedicine systems from the perspective of healthcare personnel.

    Last visit, week 8

  • Telemedicine Satisfaction and Usefulness Questionnaire (TSUQ).

    Scale designed to evaluate the satisfaction and usefulness perceived by telemedicine users from 17 to 85 points.

    Last visit, week 8

Secondary Outcomes (3)

  • European quality of life 5 dimension questionnaire (EuroQol-5D)

    week 1 and 8

  • Focus on Shoulder Pain and Disability Index (SPADI-Br).

    week 1 and 8

  • Number of patients using the platform

    week 8

Study Arms (3)

TRAK treatment group (Population 2)

EXPERIMENTAL

Patients will use Trak platform for 8 weeks (2 months) for their exercise program. The use of the tool involves performing the corresponding therapeutic exercise program through it. The frequency of the exercises will be determined by the healthcare professional responsible for the patient, based on the needs identified during the assessment, ranging from 3 to 7 days per week.

Other: Trak Telerehabilitation Platform

Control Group (Population 2)

ACTIVE COMPARATOR

Patients in the control group will undergo the same rehabilitation period (8 weeks) but following standard clinical practice.

Other: Conventional Rehabilitation Program

Healthcare professional Group (Population 1)

OTHER

Healthcare professionals who will have access to the tool to prescribe exercise sessions for their patients, monitor their progress, adapt and modify the exercise program, communicate with patients to address their questions, and track their progress over time.

Other: Trak Telerehabilitation Platform

Interventions

The exercise protocol designed is carried out through TRAK, the digital rehabilitation tool.

Healthcare professional Group (Population 1)TRAK treatment group (Population 2)

Exercise protocol with the methodology of conventional clinical practice.

Control Group (Population 2)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • They carry out their activity in a rural environment.
  • That they know how to use the tool.
  • That they have a device with which to use the tool.
  • That they have an e-mail address.
  • That they have an Internet connection.
  • That they have signed the informed consent form.

You may not qualify if:

  • N/A
  • Seniors.
  • Patients with omalgia of more than 6 months of evolution.
  • Who have a device with which to use the tool.
  • Who have a device with which to use the tool.
  • Who have an Internet connection.
  • Who have an e-mail address.
  • Who have signed the informed consent form.
  • Patients with cognitive impairment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario del Sureste

Madrid, 28500, Spain

RECRUITING

MeSH Terms

Conditions

Shoulder Pain

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • ANA VADILLO CORTÁZAR

    Hospital Universitario del Sureste

    PRINCIPAL INVESTIGATOR

Central Study Contacts

JUAN F DUARTE MENDOZA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Randomization is achieved through permuted block randomization with a 1:1 allocation ratio, ensuring balance. The intervention includes remote rehabilitation exercises supported by healthcare professionals, with outcomes assessed independently for both populations (healthcare staff and patients).
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective experimental study with 95 participants (15 from Population 1; 80 from Population 2) included based on compliance with inclusion and exclusion criteria. Population 1: Fifteen healthcare professionals will be recruited. The intervention targets patients with musculoskeletal pathologies using randomized allocation into two groups: a treatment group utilizing Trak and a control group following conventional rehabilitation methods. Population 2: Eighty patients will be randomly assigned to the experimental or control group in a 1:1 ratio.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2025

First Posted

January 28, 2025

Study Start

February 7, 2024

Primary Completion

May 1, 2025

Study Completion

May 1, 2025

Last Updated

April 8, 2025

Record last verified: 2025-04

Locations